Hyllengren Eric J
SEC CIK 1966926 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | SVP, CFO | 56.2K | — | $87.7K | 10 | 2023-05-16 | 2025-03-03 |
Most active insiders at ATRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | EcoR1 Capital, LLC | 10% | $4.74M | — |
| 2 | Panacea Innovation Ltd | 10% | — | $3.17M |
| 3 | Cherry Brian N | Dir | $1000.0K | — |
| 4 | Huang James | Dir, 10% | — | $489.0K |
| 5 | Nguyen AnhCo | Pres, CEO, Dir | — | $142.4K |
| 6 | Grant-Huerta Yanina | CAO | — | $56.5K |
| 7 | Ciongoli Gregory Austin | Dir, 10%, See Remarks | — | — |
| 8 | Redmile Group, LLC | Dir | — | — |
| 9 | Fust Matthew K | Dir | — | — |
| 10 | HEIDEN WILLIAM K | Dir | — | — |
Hyllengren Eric J made no open-market trades at ATRA in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | 2025-03-03 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | EVP, CFO, COO | S - Sale | $7.00 | -1,211 | 56.2K | -2% | -$8,477 | |
| 2025-01-29 | 2025-01-27 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | EVP, CFO, COO | A - Grant | $0.00 | +34.0K | 57.4K | +146% | $0 | |
| 2024-11-20 | 2024-11-18 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | EVP, CFO, COO | S - Sale | $11.20 | -1,364 | 23.4K | -6% | -$15.3K | |
| M | 2024-08-20 | 2024-08-16 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | EVP, CFO | S - Sale | $6.63 | -1,070 | 24.8K | -4% | -$7,094 |
| 2024-05-20 | 2024-05-16 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | EVP, CFO | S - Sale | $0.62 | -28.6K | 645.7K | -4% | -$17.8K | |
| M | 2024-03-06 | 2024-03-04 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | EVP, CFO | S - Sale | $0.72 | -6,679 | 674.3K | -1.0% | -$4,809 |
| 2024-01-09 | 2024-01-08 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | EVP, CFO | A - Grant | $0.00 | +475.0K | 681.0K | +231% | $0 | |
| 2023-11-20 | 2023-11-16 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | SVP, CFO | S - Sale | $0.39 | -12.0K | 206.0K | -5% | -$4,664 | |
| M | 2023-08-18 | 2023-08-16 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | SVP, CFO | S - Sale | $1.65 | -8,186 | 218.0K | -4% | -$13.5K |
| M | 2023-05-18 | 2023-05-16 | ATRA | Atara Biotherapeutics, Inc. | Hyllengren Eric J | SVP, CFO | S - Sale | $2.04 | -7,918 | 227.9K | -3% | -$16.2K |
Purchase Sale Sale after option exercise All abbreviations